WIRED

Wired Bio is a South San Francisco-based biotechnology company focused on developing next-generation protein therapeutics. The company leverages a proprietary protein engineering platform that integrates computational design with high-throughput screening to create biologics with enhanced precision and therapeutic potential. Wired Bio's primary focus is on addressing complex diseases in oncology and immunology by designing molecules that can overcome the limitations of traditional antibody therapies. Founded by industry veterans with backgrounds from Amgen and Genentech, the company is currently in the pre-clinical stage of development. Wired Bio aims to deliver highly specific and potent drug candidates to improve patient outcomes in high-unmet-need areas.